Koo JY - Search Results

1

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.

Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JY, Elmets CA, Korman NJ, Beutner KR, Bhushan R. Menter A, et al. Among authors: koo jy. J Am Acad Dermatol. 2008 May;58(5):826-50. doi: 10.1016/j.jaad.2008.02.039. J Am Acad Dermatol. 2008. PMID: 18423260

2

Topical therapy for psoriasis.

Lebwohl M, Abel E, Zanolli M, Koo J, Drake L. Lebwohl M, et al. Int J Dermatol. 1995 Oct;34(10):673-84. Int J Dermatol. 1995. PMID: 8537153 Review. No abstract available.

3

Cyclosporine consensus conference: with emphasis on the treatment of psoriasis.

Lebwohl M, Ellis C, Gottlieb A, Koo J, Krueger G, Linden K, Shupack J, Weinstein G. Lebwohl M, et al. J Am Acad Dermatol. 1998 Sep;39(3):464-75. doi: 10.1016/s0190-9622(98)70325-1. J Am Acad Dermatol. 1998. PMID: 9738783 Review.

4

Cost-effectiveness of methotrexate and Goeckerman therapy: a flawed analysis.

Lim HW, Anderson TF, Douglass M, Koo J, Lebwohl M, Morison W, Taylor C, Zanolli M. Lim HW, et al. Arch Dermatol. 1999 Jun;135(6):717-8. doi: 10.1001/archderm.135.6.717. Arch Dermatol. 1999. PMID: 10376708 No abstract available.

5

Duration of remission of psoriasis therapies.

Koo J, Lebwohl M. Koo J, et al. J Am Acad Dermatol. 1999 Jul;41(1):51-9. doi: 10.1016/s0190-9622(99)70406-8. J Am Acad Dermatol. 1999. PMID: 10411411 Review.

6

Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

Krueger GG, Feldman SR, Camisa C, Duvic M, Elder JT, Gottlieb AB, Koo J, Krueger JG, Lebwohl M, Lowe N, Menter A, Morison WL, Prystowsky JH, Shupack JL, Taylor JR, Weinstein GD, Barton TL, Rolstad T, Day RM. Krueger GG, et al. J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):281-5. doi: 10.1067/mjd.2000.106374. J Am Acad Dermatol. 2000. PMID: 10906652

7

The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey.

Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. Krueger G, et al. Arch Dermatol. 2001 Mar;137(3):280-4. Arch Dermatol. 2001. PMID: 11255325

8

Clearance can be a realistic expectation of psoriasis treatment.

Bowman PH, Koo JY. Bowman PH, et al. Among authors: koo jy. J Am Acad Dermatol. 2001 Sep;45(3):476. doi: 10.1067/mjd.2001.114569. J Am Acad Dermatol. 2001. PMID: 11511853 No abstract available.

9

Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis.

Lebwohl M, Drake L, Menter A, Koo J, Gottlieb AB, Zanolli M, Young M, McClelland P. Lebwohl M, et al. J Am Acad Dermatol. 2001 Oct;45(4):544-53. doi: 10.1067/mjd.2001.116347. J Am Acad Dermatol. 2001. PMID: 11568745 Review.

10

A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.

Lebwohl M, Sherer D, Washenik K, Krueger GG, Menter A, Koo J, Feldman SR. Lebwohl M, et al. Int J Dermatol. 2002 May;41(5):269-74. doi: 10.1046/j.1365-4362.2002.01431.x. Int J Dermatol. 2002. PMID: 12100701 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters